Page last updated: 2024-08-24

aripiprazole and am 251

aripiprazole has been researched along with am 251 in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ashraf, NS; Cook, D; Costa, MDC; Dharia, RM; Dulchavsky, M; Fischer, S; Gestwicki, JE; Ivanova, MI; Joshi, G; Larsen, MJ; McQuade, TJ; Ouyang, M; Paulson, HL; Schapka, E; Sun, D; Todi, SV; Yang, Y1

Other Studies

1 other study(ies) available for aripiprazole and am 251

ArticleYear
Unbiased screen identifies aripiprazole as a modulator of abundance of the polyglutamine disease protein, ataxin-3.
    Brain : a journal of neurology, 2016, 11-01, Volume: 139, Issue:11

    Topics: Animals; Animals, Genetically Modified; Antipsychotic Agents; Aripiprazole; Ataxin-3; Brain; Disease Models, Animal; Drosophila; Drug Evaluation, Preclinical; Gene Expression Regulation; HEK293 Cells; Humans; Machado-Joseph Disease; Mice; Mutant Proteins; Nerve Tissue Proteins; Organ Culture Techniques; Peptides; Piperidines; Pyrans; Pyrazoles

2016